These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19657606)

  • 1. Severe gastroparesis in a patient with advanced Parkinson's disease.
    Wang HB; Hsu CH
    Wien Klin Wochenschr; 2009; 121(13-14):445. PubMed ID: 19657606
    [No Abstract]   [Full Text] [Related]  

  • 2. [Idiopathic Parkinson's disease: practical hints for the treatment].
    Ludin HP
    Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Madopar in the complex therapy of ischemic insult].
    Odinak MM; Vozniuk IA; Kovalenko PA; Lobzin SV; Ianishevskiĭ SN
    Voen Med Zh; 2005 Jan; 326(1):35-9. PubMed ID: 15754768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA; Gachoud JP
    Praxis (Bern 1994); 1995 Oct; 84(43):1235-8. PubMed ID: 7481341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between amytrophic lateral sclerosis and Parkinson's disease].
    Alonso-Navarro H; Ruiz-Ezquerro JJ; Adeva-Bartolomé T; Jiménez-Jiménez FJ
    Med Clin (Barc); 2007 Oct; 129(12):478-9. PubMed ID: 17953916
    [No Abstract]   [Full Text] [Related]  

  • 6. Open study of sustained-release formulation of levodopa and benserazide in parkinsonian patients.
    Kostić VS; Covicković-Sternić N
    Neurologija; 1990; 39(2):99-105. PubMed ID: 2267052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficiency of new forms of madopar in Parkinson's disease].
    Vendrova MI; Sadekov RA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Madopar HBS: slow-release levodopa and benserazide in parkinsonian patients presenting marked fluctuations in symptoms on standard L-dopa treatment.
    Jensen NO; Dupont E; Hansen E; Mikkelsen B; Mikkelsen BO
    Eur Neurol; 1987; 27 Suppl 1():68-72. PubMed ID: 3428310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
    Steiger MJ; Stocchi F; Carta A; Ruggieri S; Agnoli A; Quinn NP; Marsden CD
    Clin Neuropharmacol; 1991 Jun; 14(3):241-4. PubMed ID: 2070364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay of simple reaction time after levodopa intake.
    Müller T; Benz S; Börnke C
    Clin Neurophysiol; 2001 Nov; 112(11):2133-7. PubMed ID: 11682352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations.
    Quinn NP; Marion MH; Marsden CD
    Eur Neurol; 1987; 27 Suppl 1():105-13. PubMed ID: 3322834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroparesis in a patient with Parkinson's disease.
    Sangha M; Arora A; Shulman K
    Br J Hosp Med (Lond); 2016 May; 77(5):311. PubMed ID: 27166113
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights of the North American and European experiences.
    Goetz CG
    Neurology; 1998 May; 50(5 Suppl 5):S15-6. PubMed ID: 9591517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal gastroparesis in a patient with Parkinson's disease.
    Hermanowicz N
    Mov Disord; 2008 Jan; 23(1):152-3. PubMed ID: 17987645
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
    Lombardo L; de la Garza R; Ivan-Reynoso G
    Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
    [No Abstract]   [Full Text] [Related]  

  • 16. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
    Podiwinsky F; Mentasti M; Riederer P; Birkmayer W
    Wien Klin Wochenschr; 1979 May; 91(10):332-7. PubMed ID: 452602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
    Marion MH; Stocchi F; Malcolm SL; Quinn NP; Jenner P; Marsden CD
    Eur Neurol; 1987; 27 Suppl 1():54-8. PubMed ID: 3322837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parkinson's disease and pregnancy: case report and literature review].
    Routiot T; Lurel S; Denis E; Barbarino-Monnier P
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):454-7. PubMed ID: 11011274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
    Fung VS; Herawati L; Wan Y; ;
    Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Motor fluctuations in Parkinson's disease: the "New frontier" of therapeutic success. A Roche Laboratory seminar].
    d'Anglejan Chatillon J
    Rev Prat; 1989 Mar; 39(8):689-90. PubMed ID: 2727575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.